Ignite Creation Date:
2024-05-05 @ 11:21 AM
Last Modification Date:
2024-10-26 @ 9:04 AM
Study NCT ID:
NCT00004781
Status:
COMPLETED
Last Update Posted:
2005-06-24
First Post:
2000-02-24
Brief Title:
Oral Manifestations of Human Immunodeficiency Virus Infection in High Risk Groups
Sponsor:
National Institute of Dental and Craniofacial Research NIDCR
Organization:
Office of Rare Diseases ORD
Study Overview
Official Title:
None
Status:
COMPLETED
Status Verified Date:
1997-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
OBJECTIVES I Evaluate the development of oral manifestations of human immunodeficiency virus infection in relationship to the onset of immunologic alterations and systemic symptoms in different risk groups gaybisexual men male intravenous drug users and female intravenous drug users
II Evaluate the immune and inflammatory response to periodontal and other microbial pathogens
III Evaluate the bacterial species infecting the oral cavity in patients in these risk groups
II Evaluate the immune and inflammatory response to periodontal and other microbial pathogens
III Evaluate the bacterial species infecting the oral cavity in patients in these risk groups
Detailed Description:
PROTOCOL OUTLINE
Patients undergo a periodontal assessment every 6 months until medically unable to continue The oraldental exam includes saliva and gingival crevicular fluid analysis and as indicated oral photographs
Patients undergo a periodontal assessment every 6 months until medically unable to continue The oraldental exam includes saliva and gingival crevicular fluid analysis and as indicated oral photographs
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| CU-SDOS-5059 | None | None | None |